Screener
Xeris Biopharma Holdings, Inc. XERS Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s invested capital?
- Xeris Biopharma Holdings, Inc. (XERS) reported invested capital of $157.96M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s invested capital changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s invested capital decreased by 11.6% year-over-year, from $178.63M to $157.96M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s invested capital has grown at a 14.1% compound annual growth rate (CAGR), from $83.18M to $160.75M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Xeris Biopharma Holdings, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude